These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9871424

  • 1. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
    Trapnell CB, Donahue SR, Collins JM, Flockhart DA, Thacker D, Abernethy DR.
    Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
    [Abstract] [Full Text] [Related]

  • 2. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR, Colburn W, Kook KA, Thomas SD.
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [Abstract] [Full Text] [Related]

  • 3. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C.
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [Abstract] [Full Text] [Related]

  • 4. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG, Dai Y.
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [Abstract] [Full Text] [Related]

  • 5. Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy.
    Rosenfeld WE, Doose DR, Walker SA, Nayak RK.
    Epilepsia; 1997 Mar; 38(3):317-23. PubMed ID: 9070594
    [Abstract] [Full Text] [Related]

  • 6. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP, Mathias A.
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [Abstract] [Full Text] [Related]

  • 7. Gabapentin does not interact with a contraceptive regimen of norethindrone acetate and ethinyl estradiol.
    Eldon MA, Underwood BA, Randinitis EJ, Sedman AJ.
    Neurology; 1998 Apr; 50(4):1146-8. PubMed ID: 9566412
    [Abstract] [Full Text] [Related]

  • 8. The interaction between St John's wort and an oral contraceptive.
    Hall SD, Wang Z, Huang SM, Hamman MA, Vasavada N, Adigun AQ, Hilligoss JK, Miller M, Gorski JC.
    Clin Pharmacol Ther; 2003 Dec; 74(6):525-35. PubMed ID: 14663455
    [Abstract] [Full Text] [Related]

  • 9. In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women.
    Kuhnz W, Heuner A, Hümpel M, Seifert W, Michaelis K.
    Contraception; 1997 Dec; 56(6):379-85. PubMed ID: 9494772
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetic interaction between bosentan and the oral contraceptives norethisterone and ethinyl estradiol.
    van Giersbergen PL, Halabi A, Dingemanse J.
    Int J Clin Pharmacol Ther; 2006 Mar; 44(3):113-8. PubMed ID: 16550733
    [Abstract] [Full Text] [Related]

  • 11. Tazarotene does not affect the pharmacokinetics and efficacy of a norethindrone/ethinylestradiol oral contraceptive.
    Yu Z, Yu D, Walker PS, Tang-Liu DD.
    Clin Pharmacokinet; 2004 Mar; 43(10):673-84. PubMed ID: 15244497
    [Abstract] [Full Text] [Related]

  • 12. The effect of food on the bioavailability of norethindrone and ethinyl estradiol from norethindrone acetate/ethinyl estradiol tablets intended for continuous hormone replacement therapy.
    Boyd RA, Zegarac EA, Eldon MA.
    J Clin Pharmacol; 2003 Jan; 43(1):52-8. PubMed ID: 12520628
    [Abstract] [Full Text] [Related]

  • 13. Oral contraceptives containing ethinyl estradiol and gestodene markedly increase plasma concentrations and effects of tizanidine by inhibiting cytochrome P450 1A2.
    Granfors MT, Backman JT, Laitila J, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 Oct; 78(4):400-11. PubMed ID: 16198659
    [Abstract] [Full Text] [Related]

  • 14. Lack of effect of rosiglitazone on the pharmacokinetics of oral contraceptives in healthy female volunteers.
    Inglis AM, Miller AK, Culkin KT, Finnerty D, Patterson SD, Jorkasky DK, Freed MI.
    J Clin Pharmacol; 2001 Jun; 41(6):683-90. PubMed ID: 11402638
    [Abstract] [Full Text] [Related]

  • 15. Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone.
    LeBel M, Masson E, Guilbert E, Colborn D, Paquet F, Allard S, Vallée F, Narang PK.
    J Clin Pharmacol; 1998 Nov; 38(11):1042-50. PubMed ID: 9824786
    [Abstract] [Full Text] [Related]

  • 16. [Synthetic steroids].
    Miyazaki S.
    Nihon Rinsho; 1995 Feb; 53 Su Pt 1():1036-9. PubMed ID: 8753617
    [No Abstract] [Full Text] [Related]

  • 17. Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis.
    Price TM, Dupuis RE, Carr BR, Stanczyk FZ, Lobo RA, Droegemueller W.
    Am J Obstet Gynecol; 1993 May; 168(5):1400-6. PubMed ID: 8498419
    [Abstract] [Full Text] [Related]

  • 18. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [Abstract] [Full Text] [Related]

  • 19. Dirithromycin increases ethinyl estradiol clearance without allowing ovulation.
    Wermeling DP, Chandler MH, Sides GD, Collins D, Muse KN.
    Obstet Gynecol; 1995 Jul; 86(1):78-84. PubMed ID: 7784027
    [Abstract] [Full Text] [Related]

  • 20. Effect of concomitant hormone replacement therapy containing estradiol and levonorgestrel on the pharmacokinetics of selegiline.
    Palovaara S, Anttila M, Nyman L, Laine K.
    Eur J Clin Pharmacol; 2002 Jul; 58(4):259-63. PubMed ID: 12136372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.